Clinical Trials | September 29, 2021
Morpen Labs carves out diagnostics business to unlock value
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
The tracker gives week by week coverage of the first and second dose of vaccine and also their effectiveness
Subscribe To Our Newsletter & Stay Updated
